<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Tunisia</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Tunisia.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/tn.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Cluster of imported cutaneous leishmaniasis due to Leishmania major among travellers returning from central Tunisia, France, October 2025 to May 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-32-2600605-dac5d2bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-32-2600605-dac5d2bf/</guid>
    <pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate>
    <description>The reported cluster suggests potential changes in transmission intensity in central Tunisia and highlights the value of surveillance systems for detecting imported tropical infectious diseases in European clinical settings.</description>
    <category>Leishmaniasis</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Survival analysis and mortality predictors of COVID-19 across the six-wave pattern of the pandemic in Monastir, Tunisia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13659-y-7e9eb5db/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13659-y-7e9eb5db/</guid>
    <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight the need for early identification and targeted interventions for high-risk COVID-19 patients, particularly elderly individuals and those with cancer or neurological symptoms. The temporal analysis across six waves provides evidence to inform preparedness and response strategies in similar middle-income country settings.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
</channel>
</rss>
